CINECA IRIS Institutional Research Information System

DE BORTOLI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.642
AS - Asia 8.192
EU - Europa 5.314
SA - Sud America 1.472
AF - Africa 332
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.226
SG - Singapore 2.797
CN - Cina 2.048
IT - Italia 1.989
HK - Hong Kong 1.330
BR - Brasile 1.161
VN - Vietnam 782
SE - Svezia 561
DE - Germania 504
GB - Regno Unito 410
BG - Bulgaria 389
FR - Francia 308
FI - Finlandia 295
CA - Canada 266
IN - India 218
RU - Federazione Russa 203
TR - Turchia 175
KR - Corea 169
JP - Giappone 150
AT - Austria 134
AR - Argentina 112
UA - Ucraina 104
BD - Bangladesh 103
CI - Costa d'Avorio 92
NL - Olanda 91
MX - Messico 79
PL - Polonia 70
IQ - Iraq 62
ID - Indonesia 61
ZA - Sudafrica 57
CH - Svizzera 54
ES - Italia 53
EC - Ecuador 42
PK - Pakistan 40
BE - Belgio 35
SA - Arabia Saudita 35
VE - Venezuela 32
MA - Marocco 31
UZ - Uzbekistan 29
AU - Australia 28
CO - Colombia 28
SN - Senegal 28
NG - Nigeria 26
CL - Cile 24
IR - Iran 24
EG - Egitto 22
PY - Paraguay 22
PE - Perù 21
UY - Uruguay 20
JO - Giordania 19
LT - Lituania 18
MY - Malesia 17
PH - Filippine 17
PT - Portogallo 17
KE - Kenya 16
TN - Tunisia 16
CZ - Repubblica Ceca 14
DZ - Algeria 14
IL - Israele 14
NO - Norvegia 13
TH - Thailandia 12
AZ - Azerbaigian 11
NP - Nepal 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
PA - Panama 10
LB - Libano 9
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GR - Grecia 7
OM - Oman 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
EU - Europa 6
IE - Irlanda 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
AL - Albania 5
BB - Barbados 5
DK - Danimarca 5
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BJ - Benin 3
GA - Gabon 3
GE - Georgia 3
KH - Cambogia 3
PS - Palestinian Territory 3
QA - Qatar 3
AO - Angola 2
BS - Bahamas 2
Totale 29.951
Salva come PNG Salva come JPEG
Città #
Ashburn 1.601
Singapore 1.517
Hong Kong 1.304
Fairfield 1.097
Woodbridge 1.035
San Jose 1.026
Santa Clara 888
Houston 800
Ann Arbor 759
Dallas 753
Chandler 616
Seattle 495
Shanghai 489
Serra 457
Milan 412
Cambridge 396
Sofia 388
Wilmington 385
Beijing 377
New York 335
Boardman 266
Los Angeles 235
Hefei 221
Ho Chi Minh City 205
Council Bluffs 188
Princeton 184
London 176
Ottawa 173
Lauterbourg 160
Seoul 158
Lawrence 153
Medford 146
Helsinki 140
Hanoi 134
Tokyo 131
Munich 117
Jacksonville 109
Vienna 102
Nanjing 99
Florence 97
Dong Ket 94
São Paulo 94
Abidjan 92
Des Moines 90
Redondo Beach 87
Dearborn 85
Buffalo 75
Istanbul 75
Frankfurt am Main 74
Lucca 74
Rome 66
Pisa 63
Izmir 62
San Diego 54
Orem 52
Atlanta 48
Redwood City 47
Chicago 45
Bern 43
Turku 42
Nanchang 41
Nuremberg 41
Phoenix 39
Warsaw 39
Haiphong 36
Hyderabad 36
Belo Horizonte 35
Chennai 35
Brussels 32
Denver 32
Düsseldorf 30
Ogden 30
Washington 30
Changsha 29
Falls Church 29
Tashkent 29
Dakar 28
Johannesburg 27
Rio de Janeiro 27
Toronto 27
Amsterdam 26
Brooklyn 26
Fuzhou 26
Shenyang 26
Baghdad 25
Lagos 25
Kunming 24
Dhaka 23
Guangzhou 23
Bremen 22
Lancaster 22
Da Nang 21
Falkenstein 21
Stockholm 21
Manchester 20
Curitiba 19
Hebei 19
Montreal 19
Paris 19
Brasília 18
Totale 20.783
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 547
Management of Chronic constipation in general practice 269
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 262
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 253
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 239
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 235
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 223
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 219
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 213
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 210
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 209
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 206
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 200
The Revised Reflux Symptom Index (R-RSI): Development, Internal and External Validation Study 198
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 198
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 196
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 193
Irritable bowel syndrome and chronic constipation: Fact and fiction 193
Low FODMAP diet: Evidence, doubts, and hopes 193
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 193
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 190
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 189
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 188
Management of chronic constipation in general practice. 186
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 183
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 180
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 180
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 179
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 179
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 178
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 178
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 178
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 177
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 176
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 175
Eating habits trajectories of students using university canteens 175
Radionuclide evaluation of the lower gastrointestinal tract 175
Refractory Gastroesophageal Reflux Disease: A Management Update 175
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 174
Esophageal motility abnormalities in gastroesophageal reflux disease 174
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 174
Presbifagia Esofagea 174
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 174
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 173
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 172
Updates in the field of non-esophageal gastroesophageal reflux disorder 172
Barrett's esophagus in 2016: From pathophysiology to treatment 171
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 171
Esophageal testing: What we have so far 168
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 166
Advancements in the use of manometry and impedance testing for esophageal functional disorders 166
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 165
Vonoprazan fumarate for the management of acid-related diseases 165
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 164
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 163
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 161
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 161
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 161
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 160
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 160
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 159
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 158
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 158
Evaluation of latent links between irritable bowel syndrome and sleep quality 157
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 157
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 155
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 155
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 154
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 154
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 154
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 154
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 154
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 154
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 153
The natural history of gastro-esophageal reflux disease: A comprehensive review 153
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 153
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 152
Gastrointestinal involvement in systemic sclerosis 152
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 152
High Resolution and High Definition Anorectal Manometry 152
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 151
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 151
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 151
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 149
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 147
Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0© 147
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 146
Current and future perspectives in the management of gastroesophageal reflux disease 146
Perceptual and multiparametric analysis of the voice in GERD patients 145
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 145
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 145
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 145
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 144
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 144
Is gluten the only culprit for non-celiac gluten/wheat sensitivity? 144
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 143
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 140
Totale 17.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.652 17 76 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.849 183 183 235 168 226 310 91 57 45 50 81 220
2024/20257.009 85 237 187 388 564 721 531 374 751 888 846 1.437
2025/20269.789 682 1.118 1.086 1.013 924 764 1.287 518 649 1.023 438 287
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 30.600